Radiation therapy tolerance limits: For one or for all? - Janeway lecture

Cancer

Volumn 77, Issue 11, 1996, Pages 2379-2385

  Peters, Lester J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

fibrosis; late effects; normal tissue tolerance; predictive assays; radiotherapy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

CANCER RADIOTHERAPY; CELL AGING; CELL SURVIVAL; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOSENSITIVITY; SKIN FIBROBLAST;

BIOLOGICAL ASSAY; CELL AGING; CELL SURVIVAL; CYTOKINES; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROBLASTS; HUMANS; NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; REPRODUCIBILITY OF RESULTS; SKIN; VARIATION (GENETICS);

EID: 0029897144     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2379::AID-CNCR29>3.0.CO;2-T     Document Type: Conference Paper

References (39)

1. Rubin P, Casarett G. A direction for clinical radiation pathology. Front Radiat Ther Oncol 1972;6:1-16.
2. Rubin P. Law and order of radiation sensitivity. Front Radiat Ther Oncol 1989;7-40.
3. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissues to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
4. Schultheiss TE, Stephens LC, Ang KK, Price RE, Peters LJ. Volume effects in Rhesus monkey spinal cord. Int J Radiat Oncol Biol Phys 1994;29:67-72.
5. Sherman NE, Rich TA, Peters LJ. Professional liability in radiotherapy: experience of the Fletcher Society. Int J Radiat Oncol Biol Phys 1991;20:563-6.
6. Paterson R. The treatment of malignant disease by radium and x-rays. Baltimore: The Williams & Wilkins Company, 1949.
7. Turesson I, Notter G. Skin reactions after different fractionation schedules giving the same cumulative radiation effect. Acta Radiol Ther Phys Biol 1975;14:475-84.
8. Tucker SL, Turesson I, Thames HD. Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer 1992;28A:1783-91.
9. Fu K, Pajak TF, Mardal VA, Ortiz HG, Rotman M, Asbell SO, et al. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13. Int J Radiat Oncol Biol Phys 1995;577-88.
10. Lee D-J, Pajak TF, Marcial VA, Fu KK, Rotman M, Cooper JS, et al. Results of an RTOG phase III trial (RTOG-85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys 1995;32:567-76.
11. Plowman PN, Bridges BA, Arlett CF, Hinney A, Kingston JE. An instance of clinical radiation morbidity and cellular radiosensitivity, not associated with ataxia-telangiectasia. Br J Radial 1990;63:624-8.
12. Little JB, Nove J. Sensitivity of human diploid flbroblast cell strains from various genetic disorders to acute and protracted radiation exposure. Radiat Res 1990;123:87-92.
13. Dahlberg WK, Little JB, Fletcher JA, Suit HD, Okunieff P. Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients. Int J Radiat Biol 1993;63:191-8.
14. Reinhard M, Mirand E, Goltz H, Hoffman J. Mouse strain differences in response to radiation. Proc Soc Exp Biol Med 1953;85:367-70.
15. Hornsey S. The radiosensitivity of the intestine. In: Braun H, Heuck F, Ladner H-A, Messerschmidt O, Musshoff K, Streffer C, Editors. Strahlenempfindlichkeit von Organen and Organensystemen der Säugtiere und des Menschen. Stuttgart: Georg Thieme Verlag, 1973:78-88.
16. Thames HD, Hendry JH. Fractionation in Radiotherapy. London: Taylor & Francis, 1987.
17. Hallahan DE, Haimovitz-Friedman A, Kube DW, Fuks Z, Weichselbaum RR. The role of cytokines. In: DeVita V, Hellman S, Rosenberg SA, Editors. Important advances in oncology. Philadelphia: J.B. Lippincott Co, 1993:71-80.
18. Martin M, Lefaix J-L, Pinto P, Crechet F, Daburon F. Temporal modulation of TGF-β1 and β-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 1993;134:630-70.
19. Finkelstein J, Johnston CJ, Baggs R, Rubin P. Early alterations in extracellular matrix and transforming growth factor β gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys 1994;28:621-31.
20. Anscher MS, Murase T, Prescott DM, Marks LB, Reisenbichler H, Bentel GC, et al. Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 1994;30:671-6.
21. Burnet NG, Nyman J, Turesson I, Wurm R, Yarnold JR, Peacock JH. Prediction of normal tissue tolerance to radiotherapy from in vitro cellular radiation sensitivity. Lancet 1992;339:1570-1.
22. Geara FD, Peters LJ, Ang KK, Wike JL, Brock WA. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1993;27:1173-9.
23. Tucker SL, Geara FB, Peters LJ, Brock WA. How much could the radiotherapy dose be altered for individual patients based on predictive assay of normal-tissue radiosensitivity? Radiother Oncol. 1996;38:103-13.
24. Brock WA, Tucker SL, Geara FG, Turesson I, Wike J, Nyman J, et al. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 1995;32:371-9.
25. Johansen J, Bentzen SM, Overgaard J, Overgaard M. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int J Radiat Biol 1994;66:407-12.
26. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA snythesis using an expression screen. Exp Cell Res 1994;211:90-8.
27. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
28. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-inhibiting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-16.
29. Rodemann HP, Peterson HP, Schwenke K, von Wangenheim KH. Terminal differentiation of human fibroblasts is induced by radiation. Scanning Microsc 1991;5:1135-43.
30. Reincke V, Harrison EC, Rosenblatt M, Hellman S. Proliferative capacity of murine hemopoietic stem cells in vitro. Science 1982;215:1619-22.
31. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Nat Acad Sci 1991; 89:10114-8.
32. Story MD, Mendoze EA, Meyn RE, Tofilon PJ. Pulsed-field gel electrophoretic analysis of DNA double-strand breaks in mammalian cells using photostimulable storage phosphor imaging. Int J Radiat Biol 1994;65:523-28.
33. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Zvi Y, Vanagaite L, et al. A single ataxia telangiectasia gene with a product similar to P1-3 kinase. Science 1995;268:1749-53.
34. Norman A, Kagan AR, Chan SL. The importance of genetics for the optimization of radiation therapy. A hypothesis. Am J Clin Oncol 1988;11:84-8.
35. Peters LJ. Inherent radiosensitivity of tumor and normal tissue cells as a predictor of human tumor response. Radiother Oncol 1990;17:177-90.
36. West CML, Hendry JH. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol 1992;Suppl 24:146-52.
37. Busch D. Genetic susceptibility to radiation and chemotherapy injury: diagnosis and management. Int J Radiat Oncol Biol Phys 1994;30:997-1002.
38. Budach W, Hartford A, Gioioso D, Freeman J, Alphonse T, Suit HD. Tumors arising in SCID mice share enhanced radiation sensitivity of SCID normal tissues. Cancer Res 1991;52:6292-6.
39. Hart RN, Kikler BF, Evans RG, Parks Ch. Radiotherapeutic management of medulloblastomas in a pediatric patient with ataxia telangiectasis. Int J Radiat Oncol Biol Phys 1987;13:1237-40.